BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 24850430)

  • 1. Lymph-borne CD8α+ dendritic cells are uniquely able to cross-prime CD8+ T cells with antigen acquired from intestinal epithelial cells.
    Cerovic V; Houston SA; Westlund J; Utriainen L; Davison ES; Scott CL; Bain CC; Joeris T; Agace WW; Kroczek RA; Mowat AM; Yrlid U; Milling SW
    Mucosal Immunol; 2015 Jan; 8(1):38-48. PubMed ID: 24850430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity.
    Fujimoto K; Karuppuchamy T; Takemura N; Shimohigoshi M; Machida T; Haseda Y; Aoshi T; Ishii KJ; Akira S; Uematsu S
    J Immunol; 2011 Jun; 186(11):6287-95. PubMed ID: 21525388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal CD103(-) dendritic cells migrate in lymph and prime effector T cells.
    Cerovic V; Houston SA; Scott CL; Aumeunier A; Yrlid U; Mowat AM; Milling SW
    Mucosal Immunol; 2013 Jan; 6(1):104-13. PubMed ID: 22718260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivered antigen peptides to resident CD8α
    Wang L; Wang Z; Qin Y; Liang W
    Eur J Pharm Biopharm; 2020 Feb; 147():76-86. PubMed ID: 31887349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8alpha-11b+ dendritic cells but not CD8alpha+ dendritic cells mediate cross-tolerance toward intestinal antigens.
    Chung Y; Chang JH; Kweon MN; Rennert PD; Kang CY
    Blood; 2005 Jul; 106(1):201-6. PubMed ID: 15774618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
    Chung Y; Chang JH; Kim BS; Lee JM; Kim HY; Kang CY
    Eur J Immunol; 2007 Jun; 37(6):1453-62. PubMed ID: 17474148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective T cell homing.
    Johansson-Lindbom B; Svensson M; Pabst O; Palmqvist C; Marquez G; Förster R; Agace WW
    J Exp Med; 2005 Oct; 202(8):1063-73. PubMed ID: 16216890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells.
    del Rio ML; Rodriguez-Barbosa JI; Kremmer E; Förster R
    J Immunol; 2007 Jun; 178(11):6861-6. PubMed ID: 17513734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A marked reduction in priming of cytotoxic CD8+ T cells mediated by stress-induced glucocorticoids involves multiple deficiencies in cross-presentation by dendritic cells.
    Hunzeker JT; Elftman MD; Mellinger JC; Princiotta MF; Bonneau RH; Truckenmiller ME; Norbury CC
    J Immunol; 2011 Jan; 186(1):183-94. PubMed ID: 21098225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active dissemination of cellular antigens by DCs facilitates CD8
    Gurevich I; Feferman T; Milo I; Tal O; Golani O; Drexler I; Shakhar G
    Eur J Immunol; 2017 Oct; 47(10):1802-1818. PubMed ID: 28872666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8alpha- CD11b+ dendritic cells present exogenous virus-like particles to CD8+ T cells and subsequently express CD8alpha and CD205 molecules.
    Morón G; Rueda P; Casal I; Leclerc C
    J Exp Med; 2002 May; 195(10):1233-45. PubMed ID: 12021304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells.
    Edelson BT; KC W; Juang R; Kohyama M; Benoit LA; Klekotka PA; Moon C; Albring JC; Ise W; Michael DG; Bhattacharya D; Stappenbeck TS; Holtzman MJ; Sung SS; Murphy TL; Hildner K; Murphy KM
    J Exp Med; 2010 Apr; 207(4):823-36. PubMed ID: 20351058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
    Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
    J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MyD88 Signaling Regulates Steady-State Migration of Intestinal CD103+ Dendritic Cells Independently of TNF-α and the Gut Microbiota.
    Hägerbrand K; Westlund J; Yrlid U; Agace W; Johansson-Lindbom B
    J Immunol; 2015 Sep; 195(6):2888-99. PubMed ID: 26259586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile.
    Schmidt ST; Khadke S; Korsholm KS; Perrie Y; Rades T; Andersen P; Foged C; Christensen D
    J Control Release; 2016 Oct; 239():107-17. PubMed ID: 27574990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of the cross-presenting dendritic cell subsets in the skin-draining lymph node.
    Kitano M; Yamazaki C; Takumi A; Ikeno T; Hemmi H; Takahashi N; Shimizu K; Fraser SE; Hoshino K; Kaisho T; Okada T
    Proc Natl Acad Sci U S A; 2016 Jan; 113(4):1044-9. PubMed ID: 26755602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unique functions of splenic CD8alpha+ dendritic cells during infection with intracellular pathogens.
    Neuenhahn M; Busch DH
    Immunol Lett; 2007 Dec; 114(2):66-72. PubMed ID: 17964665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.
    Duewell P; Kisser U; Heckelsmiller K; Hoves S; Stoitzner P; Koernig S; Morelli AB; Clausen BE; Dauer M; Eigler A; Anz D; Bourquin C; Maraskovsky E; Endres S; Schnurr M
    J Immunol; 2011 Jul; 187(1):55-63. PubMed ID: 21613613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anatomic location and T-cell stimulatory functions of mouse dendritic cell subsets defined by CD4 and CD8 expression.
    McLellan AD; Kapp M; Eggert A; Linden C; Bommhardt U; Bröcker EB; Kämmerer U; Kämpgen E
    Blood; 2002 Mar; 99(6):2084-93. PubMed ID: 11877283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.
    Bonifaz L; Bonnyay D; Mahnke K; Rivera M; Nussenzweig MC; Steinman RM
    J Exp Med; 2002 Dec; 196(12):1627-38. PubMed ID: 12486105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.